prolinedithiocarbamate has been researched along with Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, A; Eka Putri, S; Fudholi, A; Irfandi, R; Jarre, S; Kartina, D; Puspa Azalea, W; Ratih Tirto Sari, D; Raya, I; Santi, S | 1 |
| Katano, M; Kubo, M; Kuroki, H; Matsumoto, K; Morisaki, T; Nakamura, K; Nakamura, M; Nakashima, H; Tasaki, A; Yamanaka, N | 1 |
2 other study(ies) available for prolinedithiocarbamate and Breast Neoplasms
| Article | Year |
|---|---|
Anticancer potential of Cu(II)prolinedithiocarbamate complex: design, synthesis, spectroscopy, molecular docking, molecular dynamic, ADMET, and in-vitro studies.
Topics: Antineoplastic Agents; Breast Neoplasms; Coordination Complexes; Female; Humans; Ligands; Molecular Docking Simulation; Molecular Dynamics Simulation; Spectroscopy, Fourier Transform Infrared | 2023 |
Paclitaxel probably enhances cytotoxicity of natural killer cells against breast carcinoma cells by increasing perforin production.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Cytotoxicity, Immunologic; Female; Humans; Killer Cells, Natural; Membrane Glycoproteins; NF-kappa B; Paclitaxel; Perforin; Pore Forming Cytotoxic Proteins; Proline; Thiocarbamates; Transcription, Genetic | 2005 |